BioSpace News Archive

Policy

Patented Medicine Prices Review Board issues a Notice of Hearing for allegations of excessive pricing of Procysbi

The Patented Medicine Prices Review Board will hold a public hearing in the matter of the price of the patented medicine cysteamine bitartrate, sold under the trade name Procysbi by the patentee Horizon Therapeutics Canada.

January 16, 2019
·
2 min read
Business

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry

MIM Software Inc., a leading global provider of medical imaging software, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy (MRT) dosimetry.

January 16, 2019
·
1 min read
Business

IntriCon Hires Doug Pletcher as Vice President of Medical Business Development

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced that it has hired Doug Pletcher as Vice President of Medical Business Development.

January 16, 2019
·
2 min read
Global Ophthalmic Ultrasound Devices Market 2019-2023 | Technological Advances in Ophthalmic Ultrasound Devices to Boost Growth | Technavio

The global ophthalmic ultrasound devices market is expected to post a CAGR of over 6% during the period 2019-2023, according to the latest market research report by Technavio.

January 16, 2019
·
4 min read
Business

Research college finds that elderberry syrup has a powerful effect on cold and flu symptoms

The Franklin Institute of Wellness, an integrative health postsecondary institution, has published findings from a meta-analysis demonstrating the powerful effects of elderberry syrup on upper respiratory symptoms associated with the flu and common cold.

January 16, 2019
·
1 min read
Biotech Beach

New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders

INGREZZA Significantly Reduced the Symptoms of Involuntary Movements in Patients with Bipolar or Major Depressive Disorder in Post-Hoc Analysis

January 16, 2019
·
11 min read
Deals

Mirati Therapeutics Announces Proposed Public Offering Of Common Stock - January 16, 2019

Mirati Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, $75.0 million of shares of its common stock in an underwritten public offering.

January 16, 2019
·
4 min read
BioMidwest

Omron® HeartGuide™, the first wearable blood pressure monitor, a top award-winner at CES 2019

The new Omron Healthcare blood pressure monitor in the design of a wrist watch honored with top awards for wearables, health tech, and innovation at world’s largest annual technology innovation show

January 16, 2019
·
3 min read
Business

Universal Health Services, Inc. Announces Dividend Payable on March 15, 2019

Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.10 per share on March 15, 2019 to shareholders of record as of March 1, 2019.

January 16, 2019
·
1 min read
Biotech Beach

Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY™ (romosozumab)

Potential New Treatment Option for the Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture

January 16, 2019
·
16 min read